BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16230675)

  • 21. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
    Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
    Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U
    Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma.
    Møller MB; Pedersen NT; Christensen BE
    Am J Hematol; 2003 Oct; 74(2):94-8. PubMed ID: 14508794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
    Palmieri C; Treibel T; Large O; Bower M
    QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
    Chiao EY; Giordano TP; Richardson P; El-Serag HB
    J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
    Brumme ZL; Henrick BM; Brumme CJ; Hogg RS; Montaner JS; Harrigan PR
    Antivir Ther; 2005; 10(7):849-53. PubMed ID: 16312181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
    Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D
    Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV-related non-Hodgkin lymphoma in 45 patients; a retrospective analysis].
    Kersten MJ; Mertens MJ; Pals ST; Reiss P; van Oers MH
    Ned Tijdschr Geneeskd; 1993 Jul; 137(28):1396-400. PubMed ID: 8345893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.